Print

PAVE100

A Phase IIB Test-of-Concept, Randomized, Double-Blind, Placebo-Controlled, International Clinical Trial to Evaluate the Efficacy, Safety, and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant

Trial Details:

IIb Withdrawn
International AIDS Vaccine Initiative (IAVI), National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN), U.S. Military HIV Research Program June 01, 2007
VRC-HIVDNA016-00-VP,VRC-HIVADV014-00-VP
VRC-HIVDNA016-00-VP DNA
VRC-HIVADV014-00-VP Viral Vector - Adeno
USA
http://clinicaltrials.gov/ct2/show/NCT00498056?term=pave100&rank=1